Trevena (TRVN) Competitors

Apexigen (NASDAQ:APGN) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, analyst recommendations, valuation, dividends, risk, profitability, media sentiment and community ranking.

Does the MarketBeat Community favor APGN or TRVN?

Trevena received 610 more outperform votes than Apexigen when rated by MarketBeat users. However, 80.00% of users gave Apexigen an outperform vote while only 74.15% of users gave Trevena an outperform vote.

Company	Underperform	Outperform
Apexigen	Outperform Votes 4 80.00%	Underperform Votes 1 20.00%
Trevena	Outperform Votes 614 74.15%	Underperform Votes 214 25.85%

Do analysts rate APGN or TRVN?

Apexigen currently has a consensus price target of $11.50, suggesting a potential upside of 2,886.24%. Trevena has a consensus price target of $5.50, suggesting a potential upside of 727.69%. Given Trevena's higher possible upside, research analysts clearly believe Apexigen is more favorable than Trevena.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apexigen	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Trevena	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk & volatility, APGN or TRVN?

Apexigen has a beta of 3.6, meaning that its share price is 260% more volatile than the S&P 500. Comparatively, Trevena has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500.

Which has better valuation and earnings, APGN or TRVN?

Apexigen has higher earnings, but lower revenue than Trevena.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apexigen	N/A	N/A	-$32.07M	N/A	N/A
Trevena	$570K	15.98	-$53.67M	-$4.48	-0.15

Is APGN or TRVN more profitable?

Apexigen's return on equity of -265.73% beat Trevena's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apexigen	N/A	-614.82%	-133.30%
Trevena	N/A	-265.73%	-86.25%

Does the media prefer APGN or TRVN?

In the previous week, Trevena's average media sentiment score of 0.00 equaled Apexigen'saverage media sentiment score.

Company	Overall Sentiment
Apexigen	Neutral
Trevena	Neutral

Do insiders & institutionals have more ownership in APGN or TRVN?

13.6% of Apexigen shares are owned by institutional investors. Comparatively, 5.0% of Trevena shares are owned by institutional investors. 19.2% of Apexigen shares are owned by insiders. Comparatively, 3.3% of Trevena shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Apexigen beats Trevena on 6 of the 11 factors compared between the two stocks.